1-8 of 8
Peter C. Adamson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Open-Label, Multicenter, Phase 2/3 Study of Recombinant Crisantaspase Produced in Pseudomonas Fluorescens ( RC-P) in Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) Following Hypersensitivity to Escherichia coli -Derived Asparaginases

Luke Maese, DO, Rachel E. Rau, MD, Elizabeth A. Raetz, MD, Tong Lin, Jin Zhu, Pil Kim, Reddy Chandula, Sherrie McClung, Julie Gray, Mi Rim Choi, MD, Mignon L. Loh, MD, Peter C. Adamson
Journal: Blood
Blood (2019) 134 (Supplement_1): 2586.
https://doi.org/10.1182/blood-2019-123710
Published: 2019
Journal Articles

Reinduction Chemoimmunotherapy with Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) in Children, Adolescents and Young Adults: Results From Children's Oncology Group (COG) Study ADVL04P2

Elizabeth A. Raetz, MD, Mitchell S. Cairo, MD, Michael J. Borowitz, MD, PhD, Xiaomin Lu, PhD, Meenakshi Devidas, PhD, Joel M. Reid, PhD, David M. Goldenberg, ScD, MD, William A Wegener, MD, PhD, James A. Whitlock, MD, Peter C. Adamson, MD, Stephen P Hunger, MD, William L. Carroll, MD
Journal: Blood
Blood (2011) 118 (21): 573.
https://doi.org/10.1182/blood.V118.21.573.573
Published: 2011
Journal Articles

Merging of Children's Oncology Group and Pediatric Health Information Systems Data to Determine Resource Utilization and Treatment Costs on AAML0531: A Report From the Children's Oncology Group

Richard Aplenc, MD, PhD, Brian T. Fisher, DO, MSCE, Lillian Sung, MD, PhD, Ron Keren, MD, MSCE, Todd A. Alonzo, PhD, Mathew Hall, PhD, Yuan-Shung V. Huang, MS, Yimei Li, PhD, Xianqun Luan, PhD, Robert B. Gerbing, M.A., David Bertoch, MS, Alix E. Seif, MD, MPH, Peter C. Adamson, MD, Alan S. Gamis, MD, MPH
Journal: Blood
Blood (2011) 118 (21): 2617.
https://doi.org/10.1182/blood.V118.21.2617.2617
Published: 2011
Journal Articles

Lenalidomide (LMID) Significantly Enhances Circulating Serum Levels of IL-2 and IL-15 Levels, NK Expansion and Activation and NK and LAK Cytotoxicity in Children with Refractory/Recurrent Solid Tumors: A Children’s Oncology Group Phase I Consortium Report

Janet Ayello, MS, MT, Stacey L Berg, MD, Mark Krailo, PhD, Carmella van de Ven, MS, Ashish Mark Ingle, MS, Duane Lewis, Lauren Harrison, RN, Susan Blaney, MD, Peter C. Adamson, MD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2008) 112 (11): 107.
https://doi.org/10.1182/blood.V112.11.107.107
Published: 2008
Journal Articles

Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma

Clinical Trials & Observations
Elizabeth Fox, Bassem I. Razzouk, Brigitte C. Widemann, Shaun Xiao, Michelle O'Brien, Wendy Goodspeed, Gregory H. Reaman, Susan M. Blaney, Anthony J. Murgo, Frank M. Balis, Peter C. Adamson
Journal: Blood
Blood (2008) 111 (2): 566–573.
https://doi.org/10.1182/blood-2007-08-107839
Published: 2008
Journal Articles

Effective Targeting of Leukemic Cells in Children with B-Precursor Acute Lymphoblastic Leukemia Treated with Anti-CD22 (Epratuzumab). A Children’s Oncology Group (COG) Study.

Michael J. Borowitz, MD, PhD, William L. Carroll, MD, Peter C. Adamson, MD, Mitchell S. Cairo, MD, David M. Goldenberg, ScD, MD, William A. Wegener, MD,PhD, Elizabeth Raetz, MD
Journal: Blood
Blood (2006) 108 (11): 2585.
https://doi.org/10.1182/blood.V108.11.2585.2585
Published: 2006
Journal Articles

Pre-Clinical In Vitro Evaluation of BCL-2 Antisense Compound Genasense TM (G3139; Genta, Inc.) as a Targeted Pro-Apoptotic Agent for Leukemias with t(4;11)(q21;q23) Translocations.

Blaine W. Robinson, PhD, Kathyrn C. Behling, MD, PhD, Jeffrey S. Barrett, PhD, Manish Gupta, PhD, Jessicca M. Rege, PhD, Jonni S. Moore, PhD, Andrew D. Bantly, Junhyong Kim, PhD, George Hii, Cheryl L. Willman, MD, Jeffrey Potter, Peter C. Adamson, MD, Carolyn A. Felix, MD
Journal: Blood
Blood (2005) 106 (11): 3360.
https://doi.org/10.1182/blood.V106.11.3360.3360
Published: 2005
Journal Articles

Pan-BCL-2 Family Small Molecule Inhibitor GX015-070 (GeminX, Inc.) Exhibits Single Agent Cytotoxicity, Is Synergistic with Select Anti-Leukemia Cytotoxic Agents, and Induces Apoptosis in Cell Lines with t(4;11)(q21;q23) Translocations.

Jessicca M. Rege, PhD, Blaine W. Robinson, PhD, Manish Gupta, PhD, Jeffrey S. Barrett, PhD, Peter C. Adamson, MD, Kathryn C. Behling, MD, PhD, Andrew D. Bantly, Jonni S. Moore, PhD, Carolyn A. Felix, MD
Journal: Blood
Blood (2005) 106 (11): 3368.
https://doi.org/10.1182/blood.V106.11.3368.3368
Published: 2005